Cyclobenzaprine hydrochloride and Vaginal discharge - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Cyclobenzaprine Hydrochloride?
Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is used in muscle spasms. Currently, eHealthMe is studying from 8,088 Cyclobenzaprine hydrochloride users.
What is Vaginal Discharge?
Vaginal discharge is found to be associated with 1,651 drugs and 1,140 conditions by eHealthMe. Currently, we are studying 12,497 people who have Vaginal discharge.
Do you take Cyclobenzaprine hydrochloride and have Vaginal discharge?
Check whether Vaginal discharge is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Cyclobenzaprine hydrochloride side effects by duration, gender and age:
- Cyclobenzaprine hydrochloride side effects (8,088 reports)
Vaginal discharge treatments and more:
- Vaginal discharge (12,497 reports)
All the drugs that are associated with Vaginal discharge:
All the conditions that are associated with Vaginal discharge:
How the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Cyclobenzaprine hydrochloride) and Cyclobenzaprine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gabapentin and Eye Rolling - a second ago
- Glyset and Levaquin drug interaction - 14 seconds ago
- Orkambi and Blood Bilirubin Increased - 19 seconds ago
- Lac-Hydrin and Cozaar drug interaction - 29 seconds ago
- Nitro-Dur and Doxorubicin Hydrochloride drug interaction - 35 seconds ago
- Lovenox and Premature Rupture Of Membranes - 36 seconds ago
- Eplerenone and Simvastatin drug interaction - 40 seconds ago
- Sertraline and Tioconazole drug interaction - 40 seconds ago
- Terra-Cortril and Paclitaxel drug interaction - 41 seconds ago
- Glycopyrrolate and Metolazone drug interaction - 48 seconds ago